Cargando…
Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers
AIM: To compare therapeutic responses of a vascular-disrupting-agent, combretastatin-A4-phosphate (CA4P), among hepatocellular carcinomas (HCCs) and implanted rhabdomyosarcoma (R1) in the same rats by magnetic-resonance-imaging (MRI), microangiography and histopathology. METHODS: Thirty-six HCCs wer...
Autores principales: | Liu, Ye-Wei, De Keyzer, Frederik, Feng, Yuan-Bo, Chen, Feng, Song, Shao-Li, Swinnen, Johan, Bormans, Guy, Oyen, Raymond, Huang, Gang, Ni, Yi-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034151/ https://www.ncbi.nlm.nih.gov/pubmed/29991876 http://dx.doi.org/10.3748/wjg.v24.i25.2710 |
Ejemplares similares
-
Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation
por: Liu, Yewei, et al.
Publicado: (2020) -
Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P
por: Liu, Yewei, et al.
Publicado: (2017) -
Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI
por: Liu, Yewei, et al.
Publicado: (2019) -
Enhanced Antitumor Efficacy of a Vascular Disrupting Agent Combined with an Antiangiogenic in a Rat Liver Tumor Model Evaluated by Multiparametric MRI
por: Chen, Feng, et al.
Publicado: (2012) -
AI-based MRI auto-segmentation of brain tumor in rodents, a multicenter study
por: Wang, Shuncong, et al.
Publicado: (2023)